Serotonin and Norepinephrine Reuptake Inhibitor [EPC]

Serotonin and Norepinephrine Reuptake Inhibitor [EPC] was reported 3637 times

Drugs of the Serotonin and Norepinephrine Reuptake Inhibitor [EPC] class are most commonly taken among patients reporting these side effects:

# Drug class Count Frequency
0 GASTRIC ILEUS 20 0.3509
1 GLYCOGEN STORAGE DISORDER 5 0.1429
2 ANALGESIC DRUG LEVEL BELOW THERAPEUTIC 2 0.1429
3 ECTOPIC THYROID 2 0.1250
4 COXSACKIE VIRUS TEST POSITIVE 2 0.1000
5 PERSISTENT GENITAL AROUSAL DISORDER 18 0.0776
6 WERNICKE-KORSAKOFF SYNDROME 4 0.0635
7 POST-TRAUMATIC HEADACHE 8 0.0510
8 HYPERAROUSAL 3 0.0349
9 SYMPATHOMIMETIC EFFECT 8 0.0346
10 COMA SCALE 2 0.0328
11 ACUTE CHOLECYSTITIS NECROTIC 6 0.0299
12 ANTIDEPRESSANT DISCONTINUATION SYNDROME 6 0.0286
13 BILIRUBINURIA 3 0.0286
14 INSULINOMA 5 0.0282
15 ANTICHOLINERGIC EFFECT 2 0.0267
16 BLOOD PRESSURE ORTHOSTATIC 4 0.0252
17 COLONIC PSEUDO-OBSTRUCTION 7 0.0251
18 PAIN THRESHOLD DECREASED 3 0.0246
19 BEZOAR 27 0.0196
20 IRON OVERLOAD 20 0.0185
21 SUBSTANCE DEPENDENCE 12 0.0178
22 BINGE DRINKING 2 0.0177
23 AEROPHAGIA 3 0.0172
24 BLUNTED AFFECT 10 0.0136
25 SCHIZOPHRENIFORM DISORDER 3 0.0123
26 SOMATIC DELUSION 3 0.0122
27 EOSINOPHILIC PLEURAL EFFUSION 3 0.0101
28 ALCOHOLIC 2 0.0101
29 CHANGE IN SEIZURE PRESENTATION 6 0.0093
30 BLOOD ETHANOL INCREASED 2 0.0091
31 HYPERTENSIVE EMERGENCY 10 0.0085
32 HERBAL INTERACTION 3 0.0083
33 COMA SCALE ABNORMAL 24 0.0083
34 POSTMORTEM BLOOD DRUG LEVEL INCREASED 3 0.0080
35 POLYCYSTIC OVARIAN SYNDROME 3 0.0078
36 CONVULSIVE THRESHOLD LOWERED 3 0.0076
37 ANION GAP ABNORMAL 2 0.0075
38 BASAL GANGLIA HAEMORRHAGE 6 0.0074
39 HOMICIDE 13 0.0070
40 EAR INFLAMMATION 2 0.0069
41 EAR INFECTION FUNGAL 2 0.0066
42 SLEEP-RELATED EATING DISORDER 6 0.0064
43 SEROTONIN SYNDROME 121 0.0063
44 SUBSTANCE-INDUCED PSYCHOTIC DISORDER 14 0.0063
45 FALSE POSITIVE INVESTIGATION RESULT 6 0.0059
46 ELECTRIC SHOCK SENSATION 16 0.0057
47 DRUG-GENETIC INTERACTION 2 0.0056
48 BIPOLAR II DISORDER 2 0.0056
49 TRANSIENT GLOBAL AMNESIA 4 0.0055
50 MULTIPLE DRUG THERAPY 4 0.0053
51 BURNING MOUTH SYNDROME 3 0.0053
52 INTENTION TREMOR 3 0.0053
53 CONGENITAL DIAPHRAGMATIC HERNIA 2 0.0051
54 VASOPLEGIA SYNDROME 8 0.0049
55 PRODUCT RESIDUE PRESENT 26 0.0048
56 CONJUNCTIVITIS ALLERGIC 7 0.0047
57 INTESTINAL PSEUDO-OBSTRUCTION 4 0.0046
58 OVARIAN CANCER RECURRENT 7 0.0044
59 BLOOD PHOSPHORUS ABNORMAL 2 0.0042
60 PRETERM PREMATURE RUPTURE OF MEMBRANES 5 0.0042
61 HIGH DENSITY LIPOPROTEIN INCREASED 4 0.0040
62 CLONUS 10 0.0037
63 ALCOHOL INTERACTION 7 0.0036
64 ENDOMETRIAL THICKENING 2 0.0036
65 TOXIC ENCEPHALOPATHY 18 0.0035
66 DOSE CALCULATION ERROR 2 0.0034
67 ANTIPSYCHOTIC DRUG LEVEL ABOVE THERAPEUTIC 3 0.0034
68 BLOOD MAGNESIUM INCREASED 3 0.0033
69 CHOLINERGIC SYNDROME 2 0.0031
70 CALCIUM DEFICIENCY 4 0.0031
71 ADJUSTMENT DISORDER 4 0.0031
72 BLOOD IMMUNOGLOBULIN A DECREASED 2 0.0031
73 C-REACTIVE PROTEIN DECREASED 2 0.0031
74 YAWNING 8 0.0030
75 GASTRECTOMY 3 0.0030
76 DILATED CARDIOMYOPATHY 3 0.0030
77 CHOREOATHETOSIS 2 0.0029
78 WEIGHT ABNORMAL 7 0.0029
79 PUPIL FIXED 5 0.0029
80 FACIAL DISCOMFORT 2 0.0028
81 PRODUCT COMMINGLING 3 0.0028
82 BITE 2 0.0028
83 CUTANEOUS VASCULITIS 10 0.0027
84 BENIGN NEOPLASM OF THYROID GLAND 2 0.0027
85 DYSLEXIA 3 0.0026
86 DISTRACTIBILITY 3 0.0026
87 REVERSIBLE CEREBRAL VASOCONSTRICTION SYNDROME 5 0.0025
88 COMPLETED SUICIDE 202 0.0024
89 AUTONOMIC NERVOUS SYSTEM IMBALANCE 7 0.0024
90 EYE CONTUSION 5 0.0024
91 CRANIOFACIAL FRACTURE 2 0.0023
92 BLOOD TESTOSTERONE INCREASED 5 0.0023
93 BILIARY OBSTRUCTION 3 0.0023
94 HYPERREFLEXIA 8 0.0023
95 HYPERSENSITIVITY VASCULITIS 6 0.0023
96 POST-TRAUMATIC STRESS DISORDER 15 0.0022
97 COLITIS ISCHAEMIC 15 0.0022
98 POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME 3 0.0022
99 MONOCYTE COUNT INCREASED 8 0.0022
100 BRAIN INJURY 22 0.0022
101 AGORAPHOBIA 3 0.0022
102 SUSPECTED SUICIDE 10 0.0021
103 BUNDLE BRANCH BLOCK 2 0.0021
104 GLUTEN SENSITIVITY 3 0.0021
105 ACUTE PSYCHOSIS 5 0.0020
106 DISSOCIATION 15 0.0020
107 EUGLYCAEMIC DIABETIC KETOACIDOSIS 8 0.0019
108 ALVEOLITIS ALLERGIC 2 0.0019
109 OLIGURIA 12 0.0019
110 POISONING DELIBERATE 18 0.0019
111 DISINHIBITION 3 0.0019
112 CONGENITAL CENTRAL NERVOUS SYSTEM ANOMALY 2 0.0018
113 PRODUCT ADMINISTRATION INTERRUPTED 14 0.0018
114 MAJOR DEPRESSION 13 0.0018
115 GASTROINTESTINAL HYPOMOTILITY 4 0.0018
116 BENIGN NEOPLASM 2 0.0018
117 ACUTE SINUSITIS 3 0.0017
118 KIDNEY FIBROSIS 3 0.0017
119 LARGE INTESTINE PERFORATION 12 0.0017
120 DYSPNOEA AT REST 5 0.0017
121 ALLODYNIA 2 0.0017
122 EMOTIONAL POVERTY 3 0.0017
123 DEPRESSIVE SYMPTOM 6 0.0017
124 SKIN ABRASION 8 0.0017
125 TOXICITY TO VARIOUS AGENTS 285 0.0017
126 COLITIS MICROSCOPIC 8 0.0017
127 ATTENTION DEFICIT HYPERACTIVITY DISORDER 7 0.0017
128 INTESTINAL STENOSIS 7 0.0017
129 PARADOXICAL DRUG REACTION 6 0.0016
130 BLOOD IMMUNOGLOBULIN G DECREASED 4 0.0016
131 ALLERGY TO CHEMICALS 2 0.0016
132 SUBSTANCE ABUSE 13 0.0016
133 MOUTH SWELLING 9 0.0016
134 MOTION SICKNESS 3 0.0016
135 BLOOD PRESSURE SYSTOLIC DECREASED 7 0.0015
136 ABNORMAL SLEEP-RELATED EVENT 2 0.0015
137 AREFLEXIA 4 0.0015
138 OBSESSIVE-COMPULSIVE DISORDER 12 0.0015
139 COMPRESSION FRACTURE 8 0.0015
140 POTENTIATING DRUG INTERACTION 5 0.0015
141 SUDDEN HEARING LOSS 3 0.0015
142 GESTATIONAL DIABETES 7 0.0015
143 TROPONIN INCREASED 11 0.0014
144 PULSELESS ELECTRICAL ACTIVITY 6 0.0014
145 PHARYNGEAL SWELLING 14 0.0014
146 ALANINE AMINOTRANSFERASE ABNORMAL 3 0.0014
147 CATAPLEXY 2 0.0014
148 OCULOGYRIC CRISIS 3 0.0014
149 EYELID MARGIN CRUSTING 4 0.0014
150 EXCESSIVE EYE BLINKING 2 0.0014
151 ENTEROCOLITIS HAEMORRHAGIC 2 0.0014
152 SENSITIVITY TO WEATHER CHANGE 7 0.0013
153 NYSTAGMUS 7 0.0013
154 ASPARTATE AMINOTRANSFERASE ABNORMAL 2 0.0013
155 SUICIDAL IDEATION 120 0.0013
156 WITHDRAWAL SYNDROME 54 0.0013
157 INFUSION SITE PRURITUS 4 0.0013
158 NON-CARDIAC CHEST PAIN 4 0.0013
159 HYPERPHAGIA 5 0.0013
160 HYPOVOLAEMIC SHOCK 6 0.0013
161 IMPAIRED GASTRIC EMPTYING 17 0.0012
162 PANIC ATTACK 45 0.0012
163 COSTOCHONDRITIS 2 0.0012
164 PARANOIA 21 0.0012
165 FEELING DRUNK 9 0.0012
166 STRESS CARDIOMYOPATHY 7 0.0012
167 PERSECUTORY DELUSION 3 0.0012
168 SEDATION COMPLICATION 3 0.0012
169 FACIAL PARALYSIS 10 0.0012
170 EUPHORIC MOOD 12 0.0012
171 PSYCHOMOTOR SKILLS IMPAIRED 3 0.0011
172 INTENTIONAL OVERDOSE 73 0.0011
173 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 3 0.0011
174 HAEMORRHAGE SUBCUTANEOUS 4 0.0011
175 PROTEIN TOTAL INCREASED 3 0.0011
176 PARALYSIS 16 0.0011
177 BLOOD SODIUM INCREASED 3 0.0011
178 SKIN DISCOMFORT 3 0.0011
179 DRUG INTERACTION 174 0.0011
180 BLOOD IRON DECREASED 13 0.0011
181 BODY TEMPERATURE ABNORMAL 2 0.0011
182 SEASONAL ALLERGY 15 0.0011
183 TENDERNESS 11 0.0011
184 IMPAIRED QUALITY OF LIFE 15 0.0010
185 SUBCUTANEOUS ABSCESS 5 0.0010
186 SUICIDE ATTEMPT 62 0.0010
187 BRAIN FOG 16 0.0010
188 COELIAC DISEASE 10 0.0010
189 DECREASED INTEREST 6 0.0010
190 DRUG WITHDRAWAL SYNDROME NEONATAL 15 0.0010
191 ORGANISING PNEUMONIA 5 0.0010
192 GASTROINTESTINAL SOUNDS ABNORMAL 5 0.0010
193 ALLERGIC REACTION TO EXCIPIENT 2 0.0010
194 DUODENAL ULCER 7 0.0010
195 PRODUCT SOLUBILITY ABNORMAL 5 0.0010
196 EYE INJURY 3 0.0010
197 HOMICIDAL IDEATION 4 0.0010
198 SELF-MEDICATION 4 0.0010
199 METABOLIC ACIDOSIS 31 0.0010
200 RED CELL DISTRIBUTION WIDTH INCREASED 4 0.0010
201 SUICIDAL BEHAVIOUR 4 0.0010
202 BLOOD CREATININE DECREASED 3 0.0010
203 EAR SWELLING 2 0.0009
204 EXPOSURE TO TOXIC AGENT 3 0.0009
205 HAEMORRHAGE INTRACRANIAL 14 0.0009
206 SCAR 16 0.0009
207 ALCOHOLISM 4 0.0009
208 DEREALISATION 2 0.0009
209 HYPERPROLACTINAEMIA 6 0.0009
210 PARKINSONISM 9 0.0009
211 HYPOVENTILATION 3 0.0009
212 LYMPHOCYTE COUNT INCREASED 3 0.0009
213 HYPERTHERMIA 7 0.0009
214 SINUS TACHYCARDIA 13 0.0009
215 DYSPHEMIA 4 0.0009
216 LEFT VENTRICULAR DYSFUNCTION 6 0.0009
217 PLANTAR FASCIITIS 3 0.0009
218 AFFECTIVE DISORDER 7 0.0009
219 CHRONIC GASTRITIS 2 0.0009
220 DISTRIBUTIVE SHOCK 2 0.0009
221 INITIAL INSOMNIA 9 0.0009
222 THERAPEUTIC PRODUCT EFFECT DELAYED 4 0.0009
223 IMMUNODEFICIENCY 13 0.0009
224 DENGUE FEVER 2 0.0009
225 SHOCK 20 0.0009
226 ENCEPHALITIS 6 0.0009
227 FIBROMYALGIA 21 0.0009
228 AGITATION 63 0.0009
229 HANGOVER 3 0.0009
230 SEXUAL DYSFUNCTION 10 0.0009
231 SEDATION 22 0.0008
232 ENDOMETRIOSIS 4 0.0008
233 SLEEP APNOEA SYNDROME 16 0.0008
234 BIPOLAR DISORDER 9 0.0008
235 OVERDOSE 178 0.0008
236 SCHIZOPHRENIA 10 0.0008
237 VITAMIN D DECREASED 7 0.0008
238 UNRESPONSIVE TO STIMULI 21 0.0008
239 WOUND HAEMORRHAGE 3 0.0008
240 LIGAMENT SPRAIN 8 0.0008
241 NEURODERMATITIS 3 0.0008
242 ABDOMINAL TENDERNESS 4 0.0008
243 CHRONIC SINUSITIS 3 0.0008
244 PRODUCT SUBSTITUTION ISSUE 46 0.0008
245 EXPOSURE VIA INGESTION 2 0.0008
246 HEAD DISCOMFORT 14 0.0008
247 HAEMODYNAMIC INSTABILITY 6 0.0008
248 CLAVICLE FRACTURE 3 0.0008
249 WEIGHT LOSS POOR 4 0.0008
250 PANIC DISORDER 3 0.0008
251 DEPRESSION 176 0.0008
252 HERPES SIMPLEX 5 0.0008
253 WOUND SECRETION 3 0.0008
254 NEUROLEPTIC MALIGNANT SYNDROME 9 0.0008
255 ANIMAL BITE 2 0.0007
256 BLOOD POTASSIUM ABNORMAL 2 0.0007
257 ALCOHOL POISONING 2 0.0007
258 ANAESTHETIC COMPLICATION 2 0.0007
259 INJECTION SITE DISCHARGE 4 0.0007
260 FUNGAL SKIN INFECTION 3 0.0007
261 CRYING 27 0.0007
262 ENURESIS 3 0.0007
263 MENTAL IMPAIRMENT 18 0.0007
264 MULTIPLE ORGAN DYSFUNCTION SYNDROME 21 0.0007
265 LYMPHOCYTE COUNT DECREASED 13 0.0007
266 ASPHYXIA 6 0.0007
267 CLUMSINESS 2 0.0007
268 GENERALISED TONIC-CLONIC SEIZURE 12 0.0007
269 DRUG SCREEN FALSE POSITIVE 2 0.0007
270 INSURANCE ISSUE 11 0.0007
271 SELF-INJURIOUS IDEATION 3 0.0007
272 RESTLESS LEGS SYNDROME 13 0.0007
273 PERICARDITIS 12 0.0007
274 DELUSION 11 0.0007
275 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 12 0.0007
276 INCORRECT DRUG ADMINISTRATION RATE 3 0.0007
277 ABSCESS LIMB 3 0.0007
278 MYOCARDITIS 8 0.0007
279 TEARFULNESS 3 0.0007
280 PRODUCT ADMINISTRATION ERROR 14 0.0007
281 HALLUCINATION, AUDITORY 11 0.0007
282 PHOTOPHOBIA 13 0.0007
283 SUBARACHNOID HAEMORRHAGE 7 0.0007
284 HYPERGLYCAEMIA 25 0.0007
285 ANXIETY 194 0.0007
286 PHYSICAL DISABILITY 3 0.0007
287 ENERGY INCREASED 4 0.0007
288 ATYPICAL PNEUMONIA 2 0.0007
289 LOSS OF LIBIDO 6 0.0007
290 SINUS CONGESTION 9 0.0007
291 DYSCHEZIA 2 0.0007
292 DYSAESTHESIA 2 0.0007
293 BLOOD CHOLESTEROL ABNORMAL 3 0.0006
294 CONCOMITANT DISEASE AGGRAVATED 4 0.0006
295 CONCUSSION 5 0.0006
296 DERMATITIS ATOPIC 34 0.0006
297 EYELIDS PRURITUS 2 0.0006
298 POISONING 8 0.0006
299 ELECTROENCEPHALOGRAM ABNORMAL 2 0.0006
300 THERAPEUTIC RESPONSE CHANGED 4 0.0006
301 BLADDER PAIN 2 0.0006
302 ACCIDENTAL OVERDOSE 23 0.0006
303 MEDICATION RESIDUE PRESENT 3 0.0006
304 BLOOD CREATINE PHOSPHOKINASE INCREASED 18 0.0006
305 GALACTORRHOEA 4 0.0006
306 RHINITIS 5 0.0006
307 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 34 0.0006
308 APATHY 9 0.0006
309 APPLICATION SITE BURN 3 0.0006
310 DISORIENTATION 24 0.0006
311 INABILITY TO AFFORD MEDICATION 6 0.0006
312 ARTERIOSCLEROSIS CORONARY ARTERY 4 0.0006
313 TREATMENT NONCOMPLIANCE 33 0.0006
314 PROTEIN URINE PRESENT 3 0.0006
315 PRODUCT DOSE OMISSION IN ERROR 17 0.0006
316 INFUSION SITE ERYTHEMA 5 0.0006
317 MUSCLE RIGIDITY 7 0.0006
318 RESPIRATION ABNORMAL 4 0.0006
319 BLOOD MAGNESIUM DECREASED 5 0.0006
320 PYELONEPHRITIS 5 0.0006
321 MALABSORPTION 3 0.0006
322 NERVOUSNESS 30 0.0006
323 CATATONIA 3 0.0006
324 SPINAL OPERATION 7 0.0006
325 HYPONATRAEMIA 32 0.0006
326 SEIZURE 65 0.0006
327 CONTRAINDICATED PRODUCT ADMINISTERED 17 0.0006
328 BRUXISM 3 0.0006
329 LACTIC ACIDOSIS 18 0.0006
330 BEHAVIOUR DISORDER 3 0.0006
331 CARDIO-RESPIRATORY ARREST 23 0.0005
332 IRRITABILITY 33 0.0005
333 DEPRESSED MOOD 29 0.0005
334 NONSPECIFIC REACTION 3 0.0005
335 CHOKING SENSATION 3 0.0005
336 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 26 0.0005
337 NECROSIS 3 0.0005
338 SLEEP DISORDER 38 0.0005
339 UPPER GASTROINTESTINAL HAEMORRHAGE 9 0.0005
340 MIGRAINE 51 0.0005
341 HEMIPARESIS 9 0.0005
342 COLECTOMY 3 0.0005
343 HYPERHIDROSIS 68 0.0005
344 PRODUCT AVAILABILITY ISSUE 12 0.0005
345 INTENTIONAL DOSE OMISSION 15 0.0005
346 FEELING JITTERY 10 0.0005
347 HYPERTONIA 3 0.0005
348 THYROID DISORDER 8 0.0005
349 FOOD ALLERGY 4 0.0005
350 THROAT TIGHTNESS 14 0.0005
351 ERUCTATION 10 0.0005
352 SKIN WARM 3 0.0005
353 NICOTINE DEPENDENCE 4 0.0005
354 AKATHISIA 7 0.0005
355 MULTIPLE ALLERGIES 4 0.0005
356 GLUCOSE TOLERANCE IMPAIRED 3 0.0005
357 FRUSTRATION TOLERANCE DECREASED 4 0.0005
358 TENSION 3 0.0005
359 NEUTROPHIL COUNT INCREASED 5 0.0005
360 CARDIOMEGALY 6 0.0005
361 MANIA 8 0.0005
362 ANAPHYLACTOID REACTION 2 0.0005
363 HAIR DISORDER 4 0.0005
364 HEPATIC STEATOSIS 9 0.0005
365 MENSTRUAL DISORDER 4 0.0005
366 MIDDLE INSOMNIA 9 0.0005
367 DRUG WITHDRAWAL SYNDROME 42 0.0005
368 MOOD ALTERED 13 0.0005
369 HAEMODIALYSIS 4 0.0005
370 SCRATCH 5 0.0005
371 FULL BLOOD COUNT ABNORMAL 5 0.0005
372 OSTEOARTHRITIS 20 0.0005
373 DRUG ABUSE 39 0.0005
374 HEREDITARY ANGIOEDEMA 5 0.0005
375 DEMENTIA 13 0.0005
376 PHARYNGITIS STREPTOCOCCAL 5 0.0005
377 HYSTERECTOMY 4 0.0005
378 OSTEOPENIA 7 0.0005
379 DELIRIUM 16 0.0005
380 TARDIVE DYSKINESIA 13 0.0005
381 BONE CANCER 2 0.0005
382 REFUSAL OF TREATMENT BY PATIENT 3 0.0005
383 SOMNAMBULISM 3 0.0005
384 ASPIRATION 5 0.0005
385 ORAL CANDIDIASIS 6 0.0005
386 TOOTH INFECTION 6 0.0005
387 IMMUNOSUPPRESSION 4 0.0005
388 LUNG INFILTRATION 4 0.0005
389 CYTOMEGALOVIRUS VIRAEMIA 2 0.0004
390 THERAPY PARTIAL RESPONDER 7 0.0004
391 TERMINAL STATE 3 0.0004
392 TREATMENT FAILURE 37 0.0004
393 GASTROINTESTINAL INFECTION 4 0.0004
394 INTESTINAL PERFORATION 5 0.0004
395 DRY MOUTH 36 0.0004
396 PSORIATIC ARTHROPATHY 18 0.0004
397 DYSKINESIA 18 0.0004
398 OROPHARYNGEAL DISCOMFORT 4 0.0004
399 BLOOD THYROID STIMULATING HORMONE DECREASED 2 0.0004
400 PSYCHOTIC DISORDER 13 0.0004
401 ALANINE AMINOTRANSFERASE INCREASED 27 0.0004
402 MOOD SWINGS 14 0.0004
403 SCIATICA 7 0.0004
404 HIDRADENITIS 4 0.0004
405 EYE MOVEMENT DISORDER 3 0.0004
406 HOT FLUSH 33 0.0004
407 EAR DISORDER 2 0.0004
408 DRUG LEVEL ABOVE THERAPEUTIC 2 0.0004
409 BUNDLE BRANCH BLOCK RIGHT 2 0.0004
410 RESPIRATORY ARREST 12 0.0004
411 HIP FRACTURE 14 0.0004
412 JOINT EFFUSION 3 0.0004
413 NIGHT SWEATS 14 0.0004
414 INSOMNIA 115 0.0004
415 THINKING ABNORMAL 8 0.0004
416 FEELING OF DESPAIR 2 0.0004
417 TACHYCARDIA 38 0.0004
418 SPINAL PAIN 5 0.0004
419 HALLUCINATION, VISUAL 9 0.0004
420 COLITIS ULCERATIVE 19 0.0004
421 BLOOD SODIUM DECREASED 8 0.0004
422 THERAPEUTIC PRODUCT EFFECT DECREASED 19 0.0004
423 THERAPY NON-RESPONDER 19 0.0004
424 SPINAL DISORDER 4 0.0004
425 PRODUCT PRESCRIBING ERROR 10 0.0004
426 INCREASED APPETITE 8 0.0004
427 FAECAL INCONTINENCE 2 0.0004
428 SWOLLEN TONGUE 13 0.0004
429 AFFECT LABILITY 4 0.0004
430 PANIC REACTION 3 0.0004
431 CANDIDA INFECTION 7 0.0004
432 ATELECTASIS 4 0.0004
433 HYPOKINESIA 6 0.0004
434 DIZZINESS POSTURAL 4 0.0004
435 INTERVERTEBRAL DISC PROTRUSION 9 0.0004
436 NEURALGIA 10 0.0004
437 CIRCULATORY COLLAPSE 7 0.0004
438 INTENTIONAL UNDERDOSE 3 0.0004
439 THROMBOTIC MICROANGIOPATHY 4 0.0004
440 UTERINE LEIOMYOMA 3 0.0004
441 COVID-19 72 0.0004
442 ORAL HERPES 8 0.0004
443 KIDNEY INFECTION 8 0.0004
444 DECREASED IMMUNE RESPONSIVENESS 4 0.0004
445 COGNITIVE DISORDER 19 0.0004
446 CEREBRAL DISORDER 3 0.0004
447 DRUG EFFECT LESS THAN EXPECTED 6 0.0004
448 ARTHROPOD BITE 3 0.0004
449 NIGHTMARE 14 0.0004
450 GENERALISED OEDEMA 5 0.0004
451 RHINORRHOEA 26 0.0004
452 ORTHOSTATIC HYPOTENSION 7 0.0004
453 DISEASE RECURRENCE 19 0.0004
454 DYSARTHRIA 15 0.0004
455 BREAST TENDERNESS 3 0.0004
456 ILLNESS 41 0.0004
457 PRODUCT DOSE OMISSION ISSUE 117 0.0004
458 APHASIA 12 0.0004
459 CHOLELITHIASIS 13 0.0004
460 VERTIGO 24 0.0004
461 TREMOR 65 0.0004
462 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 2 0.0004
463 DISTURBANCE IN ATTENTION 21 0.0004
464 HALLUCINATION 29 0.0004
465 ANGER 13 0.0004
466 RESTLESSNESS 14 0.0004
467 WEIGHT FLUCTUATION 4 0.0004
468 ANHEDONIA 10 0.0004
469 ARRHYTHMIA 18 0.0004
470 DRUG SCREEN POSITIVE 3 0.0004
471 PREMATURE DELIVERY 6 0.0004
472 CARDIAC ARREST 31 0.0004
473 PRODUCT USE IN UNAPPROVED INDICATION 93 0.0004
474 POOR QUALITY SLEEP 8 0.0004
475 LIMB INJURY 10 0.0004
476 WEIGHT INCREASED 82 0.0004
477 BLOOD POTASSIUM DECREASED 11 0.0004
478 HYPERAESTHESIA 3 0.0004
479 PERIPHERAL COLDNESS 5 0.0004
480 ACUTE RESPIRATORY FAILURE 7 0.0004
481 AUTISM SPECTRUM DISORDER 2 0.0004
482 PROSTATIC SPECIFIC ANTIGEN INCREASED 5 0.0004
483 THERAPEUTIC RESPONSE SHORTENED 12 0.0004
484 PSYCHOMOTOR HYPERACTIVITY 6 0.0004
485 CYSTIC FIBROSIS 2 0.0004
486 MENTAL STATUS CHANGES 10 0.0004
487 CARPAL TUNNEL SYNDROME 5 0.0004
488 SINUS DISORDER 7 0.0004
489 MITRAL VALVE INCOMPETENCE 4 0.0004
490 CONFUSIONAL STATE 57 0.0004
491 SOMNOLENCE 71 0.0004
492 BONE DENSITY DECREASED 11 0.0004
493 CHOLECYSTECTOMY 4 0.0003
494 HYPERSOMNIA 10 0.0003
495 HAEMATOMA 9 0.0003
496 UPPER RESPIRATORY TRACT INFECTION 16 0.0003
497 HYPERTHYROIDISM 5 0.0003
498 RESPIRATORY SYNCYTIAL VIRUS INFECTION 3 0.0003
499 DISCOMFORT 21 0.0003
500 ANAPHYLACTIC REACTION 19 0.0003
501 INTENTIONAL PRODUCT USE ISSUE 30 0.0003
502 DRUG INTOLERANCE 33 0.0003
503 DRY EYE 17 0.0003
504 OSTEOPOROSIS 14 0.0003
505 COVID-19 PNEUMONIA 4 0.0003
506 SYSTEMIC LUPUS ERYTHEMATOSUS 12 0.0003
507 EXPOSURE DURING PREGNANCY 21 0.0003
508 MEMORY IMPAIRMENT 46 0.0003
509 HEAVY MENSTRUAL BLEEDING 3 0.0003
510 GASTROENTERITIS VIRAL 6 0.0003
511 LIP SWELLING 11 0.0003
512 OPTIC NEURITIS 3 0.0003
513 CONSTIPATION 72 0.0003
514 GAIT INABILITY 11 0.0003
515 EATING DISORDER 7 0.0003
516 EXOSTOSIS 3 0.0003
517 ABNORMAL BEHAVIOUR 13 0.0003
518 JOINT INJURY 7 0.0003
519 EYE PRURITUS 11 0.0003
520 ABNORMAL DREAMS 9 0.0003
521 CONDITION AGGRAVATED 99 0.0003
522 DYSPEPSIA 32 0.0003
523 ECZEMA 17 0.0003
524 INTERVERTEBRAL DISC DEGENERATION 3 0.0003
525 TENDON RUPTURE 4 0.0003
526 DRUG DIVERSION 2 0.0003
527 TENDONITIS 5 0.0003
528 SWELLING FACE 21 0.0003
529 CYST 4 0.0003
530 SINUSITIS 33 0.0003
531 WOUND 9 0.0003
532 BLOOD CHOLESTEROL INCREASED 15 0.0003
533 HEPATIC ENCEPHALOPATHY 3 0.0003
534 HAIR COLOUR CHANGES 4 0.0003
535 PRODUCT DISPENSING ERROR 7 0.0003
536 HAEMATURIA 11 0.0003
537 APPENDICITIS 3 0.0003
538 DIARRHOEA HAEMORRHAGIC 3 0.0003
539 AGEUSIA 8 0.0003
540 OXYGEN SATURATION DECREASED 18 0.0003
541 MELAENA 7 0.0003
542 COLITIS 12 0.0003
543 ABDOMINAL DISTENSION 33 0.0003
544 PRODUCT PACKAGING ISSUE 3 0.0003
545 OBESITY 5 0.0003
546 RASH PRURITIC 17 0.0003
547 SUPRAVENTRICULAR TACHYCARDIA 3 0.0003
548 VISION BLURRED 43 0.0003
549 HYPOTHYROIDISM 10 0.0003
550 FEELING ABNORMAL 75 0.0003
551 HEART RATE INCREASED 31 0.0003
552 LETHARGY 18 0.0003
553 MYDRIASIS 4 0.0003
554 CONTUSION 30 0.0003
555 ROTATOR CUFF SYNDROME 4 0.0003
556 INFUSION SITE PAIN 4 0.0003
557 FEELING HOT 19 0.0003
558 DYSGEUSIA 23 0.0003
559 CARDIAC FLUTTER 2 0.0003
560 HYPOTENSION 62 0.0003
561 HIATUS HERNIA 4 0.0003
562 MUSCLE TIGHTNESS 5 0.0003
563 DYSSTASIA 9 0.0003
564 SKIN FISSURES 6 0.0003
565 NEPHROLITHIASIS 14 0.0003
566 GASTRITIS 8 0.0003
567 URINARY INCONTINENCE 9 0.0003
568 IMMUNE SYSTEM DISORDER 4 0.0003
569 HYPOKALAEMIA 14 0.0003
570 C-REACTIVE PROTEIN INCREASED 11 0.0003
571 BLADDER DISORDER 3 0.0003
572 BLOOD PRESSURE DECREASED 20 0.0003
573 DIZZINESS 150 0.0003
574 FLATULENCE 17 0.0003
575 HAIR TEXTURE ABNORMAL 4 0.0003
576 PARAESTHESIA 47 0.0003
577 TOXIC SKIN ERUPTION 3 0.0003
578 INTENTIONAL PRODUCT MISUSE 26 0.0003
579 EYE SWELLING 11 0.0003
580 FALL 98 0.0003
581 ANGIOEDEMA 13 0.0003
582 ABNORMAL LOSS OF WEIGHT 2 0.0003
583 BLOOD TESTOSTERONE DECREASED 2 0.0003
584 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 3 0.0003
585 NAUSEA 231 0.0003
586 MATERNAL EXPOSURE DURING PREGNANCY 26 0.0003
587 OROPHARYNGEAL PAIN 27 0.0003
588 EYE DISCHARGE 3 0.0003
589 DIVERTICULITIS 8 0.0003
590 FEELING COLD 8 0.0003
591 HUNGER 4 0.0003
592 ROAD TRAFFIC ACCIDENT 12 0.0003
593 WHEEZING 17 0.0003
594 DERMATITIS 6 0.0003
595 NECK PAIN 16 0.0003
596 MUSCULOSKELETAL STIFFNESS 25 0.0003
597 COLD SWEAT 5 0.0003
598 BLINDNESS UNILATERAL 4 0.0003
599 TINNITUS 13 0.0003
600 FOETAL EXPOSURE DURING PREGNANCY 23 0.0003
601 BLOOD ALKALINE PHOSPHATASE INCREASED 7 0.0003
602 DIVERTICULUM 2 0.0003
603 RETCHING 6 0.0003
604 BODY HEIGHT DECREASED 3 0.0003
605 THIRST 5 0.0003
606 DEPRESSED LEVEL OF CONSCIOUSNESS 11 0.0003
607 PARAESTHESIA ORAL 4 0.0003
608 DEEP VEIN THROMBOSIS 18 0.0003
609 SKIN LACERATION 3 0.0003
610 MENTAL DISORDER 12 0.0003
611 PNEUMONIA 89 0.0003
612 CLOSTRIDIUM DIFFICILE INFECTION 6 0.0003
613 URTICARIA 46 0.0003
614 HEADACHE 172 0.0003
615 CHEST DISCOMFORT 28 0.0003
616 CHILLS 32 0.0003
617 DRUG RESISTANCE 7 0.0003
618 CARDIOMYOPATHY 4 0.0003
619 DEHYDRATION 36 0.0003
620 SKIN HAEMORRHAGE 4 0.0003
621 URINARY RETENTION 9 0.0003
622 OBSTRUCTIVE AIRWAYS DISORDER 3 0.0003
623 HYPERTENSIVE CRISIS 3 0.0003
624 HYPERTENSION 57 0.0003
625 PULMONARY MASS 4 0.0003
626 GLOSSODYNIA 6 0.0003
627 ORAL PAIN 6 0.0003
628 RASH PAPULAR 6 0.0003
629 SKIN INFECTION 3 0.0003
630 MUCOSAL INFLAMMATION 7 0.0003
631 OFF LABEL USE 234 0.0003
632 HYPOAESTHESIA ORAL 4 0.0003
633 INTESTINAL OBSTRUCTION 10 0.0003
634 SCAB 3 0.0003
635 GASTROOESOPHAGEAL REFLUX DISEASE 21 0.0003
636 INJECTION SITE RASH 8 0.0003
637 PRODUCT USE ISSUE 49 0.0003
638 WHITE BLOOD CELL COUNT INCREASED 10 0.0003
639 MUSCLE TWITCHING 6 0.0003
640 PHARYNGEAL OEDEMA 4 0.0003
641 AGGRESSION 13 0.0003
642 GLAUCOMA 5 0.0003
643 PERICARDIAL EFFUSION 6 0.0003
644 MADAROSIS 3 0.0003
645 MENINGIOMA 4 0.0003
646 SURGERY 15 0.0003
647 FLUSHING 26 0.0003
648 DISABILITY 5 0.0003
649 ATAXIA 3 0.0003
650 PSORIASIS 33 0.0003
651 HAEMATOCRIT DECREASED 5 0.0003
652 INFLAMMATION 13 0.0003
653 CHOLECYSTITIS 3 0.0003
654 MYOCLONUS 3 0.0003
655 BLOOD PRESSURE ABNORMAL 5 0.0003
656 UPPER LIMB FRACTURE 5 0.0003
657 MULTIPLE SCLEROSIS 12 0.0003
658 SYNCOPE 25 0.0002
659 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 45 0.0002
660 BLOOD DISORDER 2 0.0002
661 SPINAL FRACTURE 5 0.0002
662 SPEECH DISORDER 13 0.0002
663 MULTIPLE SCLEROSIS RELAPSE 17 0.0002
664 PRODUCT PHYSICAL ISSUE 5 0.0002
665 PAIN IN JAW 7 0.0002
666 TASTE DISORDER 5 0.0002
667 BLOOD POTASSIUM INCREASED 4 0.0002
668 NO THERAPEUTIC RESPONSE 3 0.0002
669 BACK DISORDER 4 0.0002
670 PRODUCT DOSE OMISSION 16 0.0002
671 INJECTION SITE URTICARIA 6 0.0002
672 LIVER INJURY 6 0.0002
673 BALANCE DISORDER 21 0.0002
674 BLOOD PRESSURE INCREASED 37 0.0002
675 INJURY 17 0.0002
676 ARTHRITIS 19 0.0002
677 PERITONITIS 5 0.0002
678 DECREASED APPETITE 56 0.0002
679 TOOTH EXTRACTION 3 0.0002
680 HYPOAESTHESIA 36 0.0002
681 WHITE BLOOD CELL COUNT DECREASED 26 0.0002
682 POLLAKIURIA 10 0.0002
683 PRURITUS 92 0.0002
684 MOBILITY DECREASED 17 0.0002
685 HEPATITIS 6 0.0002
686 DRUG INEFFECTIVE 309 0.0002
687 RESPIRATORY DISORDER 7 0.0002
688 IMPAIRED WORK ABILITY 5 0.0002
689 ADVERSE DRUG REACTION 21 0.0002
690 THERAPY CESSATION 12 0.0002
691 FATIGUE 182 0.0002
692 ERECTILE DYSFUNCTION 6 0.0002
693 IRRITABLE BOWEL SYNDROME 5 0.0002
694 MUSCULOSKELETAL DISCOMFORT 4 0.0002
695 VOMITING 109 0.0002
696 LACRIMATION INCREASED 7 0.0002
697 INCORRECT PRODUCT ADMINISTRATION DURATION 5 0.0002
698 ALTERED STATE OF CONSCIOUSNESS 5 0.0002
699 DEVICE DEFECTIVE 4 0.0002
700 RESPIRATORY TRACT INFECTION 6 0.0002
701 INCORRECT DOSE ADMINISTERED BY DEVICE 6 0.0002
702 NEUROTOXICITY 4 0.0002
703 EOSINOPHILIA 4 0.0002
704 BEDRIDDEN 3 0.0002
705 BLOOD CALCIUM INCREASED 2 0.0002
706 ANKYLOSING SPONDYLITIS 3 0.0002
707 BREAST CANCER FEMALE 6 0.0002
708 INFLUENZA 25 0.0002
709 FACIAL PAIN 2 0.0002
710 BACK PAIN 52 0.0002
711 CHRONIC KIDNEY DISEASE 17 0.0002
712 QUALITY OF LIFE DECREASED 3 0.0002
713 ABDOMINAL PAIN 52 0.0002
714 ASTHENIA 84 0.0002
715 THERAPEUTIC RESPONSE UNEXPECTED 10 0.0002
716 THROAT IRRITATION 10 0.0002
717 ELECTROCARDIOGRAM QT PROLONGED 8 0.0002
718 CHROMATURIA 5 0.0002
719 HEAD INJURY 7 0.0002
720 ASTHMA 25 0.0002
721 PERIPHERAL SWELLING 34 0.0002
722 TACHYPNOEA 3 0.0002
723 URINARY TRACT INFECTION 37 0.0002
724 CONJUNCTIVITIS 4 0.0002
725 COORDINATION ABNORMAL 3 0.0002
726 PALPITATIONS 25 0.0002
727 EYE DISORDER 7 0.0002
728 ARTERIOSCLEROSIS 2 0.0002
729 ABORTION INDUCED 2 0.0002
730 DYSPNOEA EXERTIONAL 8 0.0002
731 DYSPNOEA 120 0.0002
732 PAIN 130 0.0002
733 NASOPHARYNGITIS 39 0.0002
734 FOOT FRACTURE 4 0.0002
735 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 15 0.0002
736 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 11 0.0002
737 DYSPHAGIA 20 0.0002
738 BLOOD URINE PRESENT 4 0.0002
739 GASTRIC ULCER 4 0.0002
740 VIRAL INFECTION 7 0.0002
741 RED BLOOD CELL COUNT DECREASED 6 0.0002
742 POST PROCEDURAL COMPLICATION 4 0.0002
743 TRANSIENT ISCHAEMIC ATTACK 7 0.0002
744 ANOSMIA 3 0.0002
745 COUGH 58 0.0002
746 AUTOIMMUNE DISORDER 2 0.0002
747 DYSPHONIA 12 0.0002
748 CHEST PAIN 38 0.0002
749 HAEMORRHOIDS 4 0.0002
750 ABDOMINAL PAIN UPPER 42 0.0002
751 ALOPECIA 40 0.0002
752 OSTEONECROSIS OF JAW 5 0.0002
753 RENAL INJURY 6 0.0002
754 RASH MACULAR 7 0.0002
755 BURNING SENSATION 14 0.0002
756 BLOOD CREATININE INCREASED 13 0.0002
757 THERAPEUTIC RESPONSE DECREASED 12 0.0002
758 BLOOD COUNT ABNORMAL 3 0.0002
759 ILL-DEFINED DISORDER 12 0.0002
760 SEPSIS 22 0.0002
761 DEVICE FAILURE 3 0.0002
762 DRY THROAT 2 0.0002
763 ABDOMINAL DISCOMFORT 33 0.0002
764 EPILEPSY 6 0.0002
765 INFUSION RELATED REACTION 13 0.0002
766 SKIN DISCOLOURATION 9 0.0002
767 ADVERSE EVENT 18 0.0002
768 LOSS OF CONSCIOUSNESS 25 0.0002
769 EYE PAIN 11 0.0002
770 MYALGIA 33 0.0002
771 INJECTION SITE PRURITUS 13 0.0002
772 HYPERSENSITIVITY 36 0.0002
773 LIMB DISCOMFORT 6 0.0002
774 SWELLING 18 0.0002
775 NERVOUS SYSTEM DISORDER 6 0.0002
776 RHABDOMYOLYSIS 8 0.0002
777 JOINT SWELLING 23 0.0002
778 GASTROINTESTINAL DISORDER 17 0.0002
779 RESPIRATORY TRACT CONGESTION 3 0.0002
780 GAIT DISTURBANCE 36 0.0002
781 ABSCESS 3 0.0002
782 BREAST PAIN 2 0.0002
783 SENSORY DISTURBANCE 3 0.0002
784 MOVEMENT DISORDER 6 0.0002
785 BREAST CANCER METASTATIC 2 0.0002
786 DRUG EFFECT DECREASED 10 0.0002
787 HYPOGLYCAEMIA 9 0.0002
788 DECREASED ACTIVITY 2 0.0002
789 FREQUENT BOWEL MOVEMENTS 5 0.0002
790 MUSCULAR WEAKNESS 21 0.0002
791 AMNESIA 12 0.0002
792 BACK INJURY 2 0.0002
793 MULTIPLE FRACTURES 3 0.0002
794 MALAISE 80 0.0002
795 STAPHYLOCOCCAL INFECTION 6 0.0002
796 DRUG LEVEL INCREASED 3 0.0002
797 DENTAL CARIES 2 0.0002
798 ARTHRALGIA 75 0.0002
799 COAGULOPATHY 3 0.0002
800 TOOTH DISORDER 4 0.0002
801 RASH 78 0.0002
802 NEUROPATHY PERIPHERAL 17 0.0002
803 RESPIRATORY FAILURE 13 0.0002
804 BLOOD CALCIUM DECREASED 2 0.0002
805 VISUAL IMPAIRMENT 22 0.0002
806 EYE INFECTION 2 0.0002
807 FLUID RETENTION 9 0.0002
808 DIARRHOEA 111 0.0002
809 WEIGHT DECREASED 48 0.0002
810 DIABETES MELLITUS 13 0.0002
811 NASAL CONGESTION 10 0.0002
812 BLOOD TRIGLYCERIDES INCREASED 3 0.0002
813 ACUTE MYOCARDIAL INFARCTION 5 0.0002
814 MUSCLE SPASMS 31 0.0002
815 PULMONARY EMBOLISM 16 0.0002
816 PRODUCT ADHESION ISSUE 6 0.0002
817 CATARACT 10 0.0002
818 THERAPY INTERRUPTED 12 0.0002
819 ACCIDENT 2 0.0002
820 RASH ERYTHEMATOUS 8 0.0002
821 BLOOD PRESSURE FLUCTUATION 4 0.0002
822 PAIN IN EXTREMITY 49 0.0002
823 PREMATURE BABY 5 0.0002
824 PRESYNCOPE 4 0.0002
825 END STAGE RENAL DISEASE 3 0.0002
826 UNDERDOSE 12 0.0002
827 CYTOPENIA 2 0.0002
828 ENCEPHALOPATHY 4 0.0002
829 HYPOACUSIS 7 0.0002
830 BRONCHITIS 12 0.0002
831 BACTERIAL INFECTION 3 0.0002
832 LEUKOPENIA 8 0.0002
833 INJECTION SITE REACTION 11 0.0002
834 FRACTURE 3 0.0002
835 INFLUENZA LIKE ILLNESS 13 0.0002
836 HAEMATEMESIS 4 0.0002
837 MUSCULOSKELETAL DISORDER 3 0.0002
838 EMOTIONAL DISTRESS 19 0.0002
839 HYPOPHAGIA 4 0.0002
840 GENERAL PHYSICAL HEALTH DETERIORATION 18 0.0002
841 PRESCRIBED OVERDOSE 3 0.0002
842 SKIN ULCER 4 0.0002
843 EXPOSURE VIA SKIN CONTACT 4 0.0002
844 EAR PAIN 3 0.0002
845 SKIN BURNING SENSATION 11 0.0002
846 ADVERSE REACTION 2 0.0002
847 EYE HAEMORRHAGE 2 0.0001
848 PREGNANCY 3 0.0001
849 FEAR 4 0.0001
850 PAIN OF SKIN 4 0.0001
851 INTENTIONAL SELF-INJURY 3 0.0001
852 BLOOD BILIRUBIN INCREASED 4 0.0001
853 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 30 0.0001
854 PLEURAL EFFUSION 9 0.0001
855 NEUTROPHIL COUNT DECREASED 6 0.0001
856 PALLOR 4 0.0001
857 PRODUCTIVE COUGH 7 0.0001
858 PRODUCT PREPARATION ERROR 3 0.0001
859 ERYTHEMA 30 0.0001
860 INJECTION SITE WARMTH 3 0.0001
861 SKIN LESION 4 0.0001
862 CENTRAL NERVOUS SYSTEM LESION 2 0.0001
863 INJECTION SITE ERYTHEMA 18 0.0001
864 HAEMATOCHEZIA 8 0.0001
865 GASTROINTESTINAL HAEMORRHAGE 12 0.0001
866 HAEMOPTYSIS 4 0.0001
867 DRY SKIN 19 0.0001
868 ANAEMIA 27 0.0001
869 INJECTION SITE PAIN 43 0.0001
870 ANGINA PECTORIS 4 0.0001
871 OEDEMA PERIPHERAL 17 0.0001
872 PRURITUS GENERALISED 3 0.0001
873 INJECTION SITE BRUISING 11 0.0001
874 COMPLICATION ASSOCIATED WITH DEVICE 2 0.0001
875 ACUTE KIDNEY INJURY 21 0.0001
876 BONE PAIN 8 0.0001
877 PYREXIA 47 0.0001
878 LABORATORY TEST ABNORMAL 4 0.0001
879 LIVER DISORDER 6 0.0001
880 INJECTION SITE MASS 5 0.0001
881 TRANSAMINASES INCREASED 3 0.0001
882 MUSCULOSKELETAL PAIN 7 0.0001
883 NEUTROPENIA 18 0.0001
884 APPLICATION SITE PRURITUS 3 0.0001
885 ECONOMIC PROBLEM 2 0.0001
886 INFECTION 19 0.0001
887 SKIN EXFOLIATION 11 0.0001
888 DEVICE ADHESION ISSUE 2 0.0001
889 DEVICE RELATED INFECTION 2 0.0001
890 EMOTIONAL DISORDER 4 0.0001
891 ANKLE FRACTURE 2 0.0001
892 EJECTION FRACTION DECREASED 2 0.0001
893 CARDIAC DISORDER 12 0.0001
894 PLASMA CELL MYELOMA 5 0.0001
895 OCULAR HYPERAEMIA 6 0.0001
896 BLOOD LACTATE DEHYDROGENASE INCREASED 2 0.0001
897 DIABETIC KETOACIDOSIS 3 0.0001
898 THROMBOSIS 10 0.0001
899 DEVICE ISSUE 11 0.0001
900 PLATELET COUNT DECREASED 13 0.0001
901 IMPAIRED HEALING 4 0.0001
902 HERPES ZOSTER 7 0.0001
903 FEBRILE NEUTROPENIA 8 0.0001
904 FUNGAL INFECTION 4 0.0001
905 TYPE 2 DIABETES MELLITUS 4 0.0001
906 CARDIOVASCULAR DISORDER 3 0.0001
907 RENAL FAILURE ACUTE 5 0.0001
908 INJECTION SITE SWELLING 9 0.0001
909 HEPATIC ENZYME INCREASED 8 0.0001
910 HAEMOGLOBIN DECREASED 12 0.0001
911 VAGINAL HAEMORRHAGE 5 0.0001
912 HAEMORRHAGE 12 0.0001
913 RHEUMATOID ARTHRITIS 13 0.0001
914 AMENORRHOEA 2 0.0001
915 BRADYCARDIA 6 0.0001
916 EAR INFECTION 3 0.0001
917 DRUG DEPENDENCE 18 0.0001
918 PULMONARY OEDEMA 5 0.0001
919 JAUNDICE 3 0.0001
920 OEDEMA 6 0.0001
921 COMPLICATION OF DEVICE REMOVAL 2 0.0001
922 DISEASE PROGRESSION 13 0.0001
923 RESPIRATORY DISTRESS 3 0.0001
924 PROCEDURAL PAIN 3 0.0001
925 ARTHROPATHY 6 0.0001
926 AGRANULOCYTOSIS 2 0.0001
927 UNEVALUABLE EVENT 8 0.0001
928 INTERNATIONAL NORMALISED RATIO INCREASED 3 0.0001
929 NEEDLE ISSUE 3 0.0001
930 ATRIAL FIBRILLATION 10 0.0001
931 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 3 0.0001
932 CELLULITIS 5 0.0001
933 THROMBOCYTOPENIA 11 0.0001
934 BLINDNESS 4 0.0001
935 BODY TEMPERATURE INCREASED 2 0.0001
936 BREAST CANCER 9 0.0001
937 INCORRECT DOSE ADMINISTERED 22 0.0001
938 PRODUCT QUALITY ISSUE 13 0.0001
939 RENAL IMPAIRMENT 8 0.0001
940 CYSTITIS 3 0.0001
941 ASPARTATE AMINOTRANSFERASE INCREASED 5 0.0001
942 ACNE 7 0.0001
943 DEVICE DISLOCATION 4 0.0001
944 OSTEONECROSIS 3 0.0001
945 RENAL FAILURE 12 0.0001
946 EXPIRED PRODUCT ADMINISTERED 3 0.0001
947 INJECTION SITE HAEMORRHAGE 7 0.0001
948 GASTRIC DISORDER 3 0.0001
949 ACCIDENTAL EXPOSURE TO PRODUCT 9 0.0001
950 SKIN IRRITATION 4 0.0001
951 CARDIAC FAILURE 7 0.0001
952 EYE IRRITATION 5 0.0001
953 NEOPLASM PROGRESSION 3 0.0001
954 MYOCARDIAL INFARCTION 15 0.0001
955 RENAL DISORDER 4 0.0001
956 HEART RATE DECREASED 3 0.0001
957 HYPOXIA 3 0.0001
958 LYMPHADENOPATHY 3 0.0001
959 CEREBRAL HAEMORRHAGE 3 0.0001
960 BLOOD GLUCOSE DECREASED 4 0.0001
961 DRUG EFFECT INCOMPLETE 3 0.0001
962 STOMATITIS 5 0.0001
963 BLOOD GLUCOSE INCREASED 15 0.0001
964 HOSPITALISATION 12 0.0001
965 DIPLOPIA 2 0.0001
966 PANCREATITIS 4 0.0001
967 ABORTION SPONTANEOUS 3 0.0001
968 EXTRA DOSE ADMINISTERED 3 0.0001
969 DEVICE BREAKAGE 3 0.0001
970 BLISTER 4 0.0001
971 CEREBROVASCULAR ACCIDENT 12 0.0001
972 DEVICE LEAKAGE 3 0.0001
973 PRODUCT STORAGE ERROR 6 0.0001
974 ASCITES 2 0.0001
975 DRUG DOSE OMISSION 11 0.0001
976 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 3 0.0001
977 DRUG DOSE OMISSION BY DEVICE 5 0.0001
978 DRUG-INDUCED LIVER INJURY 2 0.0001
979 COMA 3 0.0001
980 DEATH 54 0.0001
981 CARDIAC FAILURE CONGESTIVE 5 0.0001
982 INTERSTITIAL LUNG DISEASE 3 0.0001
983 DEVICE DIFFICULT TO USE 4 0.0001
984 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 2 0.0001
985 DRUG EXPOSURE DURING PREGNANCY 2 0.0001
986 DEVICE USE ERROR 2 0.0001
987 NO ADVERSE EVENT 10 0.0001
988 DYSURIA 2 0.0001
989 EPISTAXIS 4 0.0001
990 MALIGNANT NEOPLASM PROGRESSION 5 0.0000
991 DEVICE MALFUNCTION 3 0.0000
992 CONVULSION 2 0.0000